No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

SurgiSTUD Launches a New Orthopedic Subdivision in their STUD Catalog

Editor: What To Know

  • We understand the need for cost-effective and consistent training models and made it our mission to find a solution that can provide medical professionals and R&D teams a safer and more affordable approach to medical education while maintaining the same educational experience as traditional cadavers.
  • As the medical industry experiences delays, cancellations, and rising costs due to cadaver shortages, SurgiSTUD is continuing to step up to provide surgical training and utility devices that provide a superior platform that will now cover orthopedics along with their spine devices.
  • The addition of the orthopedic models to their catalog, including knee, hip, shoulder, and foot models, provides a needed, alternate solution to expensive cadavers that are currently used in the training of orthopedic surgeons.

SurgiSTUD (STUD is an acronym for Surgical Training Utility Device), announced it’s launching a new orthopedic subdivision in their STUD catalog. These STUDs are surgical training models with superior biomechanical fidelity, customizability, and cost-savings over existing cadaveric and synthetic training options.

The addition of the orthopedic models to their catalog, including knee, hip, shoulder, and foot models, provides a needed, alternate solution to expensive cadavers that are currently used in the training of orthopedic surgeons.

What this means:

  • Customers have a consistent and repeatable training platform that can be delivered across the globe.
  • Customers can increase the number of training sessions while reducing the overall economic spend.
  • Customers no longer have to delay training or medical education due to cadaver shortages.
  • Customers can order customized models that can improve medical training by mimicking specified pathology and deformities they are training for.
  • Training can be conducted in places beyond a lab as all models are synthetic.

“We are happy to expand our catalog of STUDs to include orthopedics. We understand the need for cost-effective and consistent training models and made it our mission to find a solution that can provide medical professionals and R&D teams a safer and more affordable approach to medical education while maintaining the same educational experience as traditional cadavers.” – John Brambert, Executive Vice President SurgiSTUD.

As the medical industry experiences delays, cancellations, and rising costs due to cadaver shortages, SurgiSTUD is continuing to step up to provide surgical training and utility devices that provide a superior platform that will now cover orthopedics along with their spine devices.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy